Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.（MIRM）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
mirm · 股价预测 · 18 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 18 位华尔街分析师
Buy
18 位分析师
共识
评级分布
12 个月目标价
High
$185
Consensus
$143
+52.5% upside
Low
$118
Median: $140 · Last Close: $93.48
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$142.55
52.5% upside
High Target
$185
97.9%
Low Target
$118
26.2%
Current Price
$93.48
as of today
Based on analyst price targets, the MIRM stock price prediction for the next 12 months ranges from $118 to $185. The consensus MIRM price forecast of $142.55 implies 52.5% upside from the current price of $93.48.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $89.41 | ↓ 4.35% |
1-day model range: $88.82–$90. Peak: $90 (-4.35%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $167 | +78.5% |
| 2028 | $245 | +162.5% |
| 2029 | $315 | +236.6% |
| 2030 | $368 | +293.6% |
| 2031 | — | +333.7% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · MIRM · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-07 | Baird | Maintains | Outperform→Outperform |
| 2026-05-07 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2026-05-07 | RBC Capital | Maintains | Outperform→Outperform |
| 2026-05-07 | TD Cowen | Maintains | Buy→Buy |
| 2026-05-05 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-29 | Stifel | Maintains | Buy→Buy |
| 2026-04-28 | Baird | Maintains | Outperform→Outperform |
| 2026-04-27 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-21 | Citizens | Maintains | Market Outperform→Market Outperform |
Wall Street analysts have recently issued updated ratings on Mirum Pharmaceuticals, Inc. (MIRM) stock. Of the recent 119 rating actions, 1 were upgrades and 0 were downgrades. 18 analysts currently cover MIRM.
分析师推荐趋势
MIRM analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 6 to 6 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$674M
↓ 36.3% YoY
Revenue Next Year
$811M
↑ 20.2% YoY
EPS This Year
$-15.65
EPS Next Year
$-0.68
↓ 95.6% YoY
EPS ForecastReported vs Estimated
Analysts forecast MIRM EPS of $-15.65 for the current fiscal year, based on estimates from 7 analysts. The MIRM revenue forecast is $674M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
MIRM 股价预测由两类独立数据源支撑：来自 18 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。MIRM 的共识目标价为 $142.55（+52.5% 上行空间），分析师共识为 Buy。
MIRM 的短期预测（明日）为 $89.41（-4.35%）。 MIRM 对 2027 年的股价预测均值为 $167。 MIRM 对 2030 年的预测区间为 $341–$395。
Mirum Pharmaceuticals, Inc. 在 NASDAQ 上市，代码 MIRM。MIRM 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
MIRM 预测 · 8 个问题根据 18 位华尔街分析师，MIRM 的 12 个月平均目标价为 $142.55，最高 $185.00、最低 $118.00。若有图表，中位目标价可在上方查看。相对当前价 $93.48，隐含约 +52.5% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.